This website uses cookies

We use cookies to ensure you get the best experience. Check our Privacy Policy

Manage Cookies

Manage Cookies

You can choose to enable or disable some or all of these cookies but disabling some of them may affect your browsing experience.

Advertisement

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously

Analytics

Analytical cookies are used to understand how visitors interact with the website.

Functional

Functional cookies help perform certain functionalities like collecting feedback, and other third-party features.

Performance

Performance cookies are used to understand and analyze the key performance indexes of the website.

tm logo
VOLITION
Live/Pending
WITHDRAWN BEFORE PUBLICATION

on 18 Nov 2024

Last Applicant/ Owned by

22 Rue Phocas Lejeune

Isnes

BE

BE-5032

Serial Number

98208918 filed on 04th Oct 2023

Registration Number

N/A

Correspondent Address

Amanda G. Hyland

Amanda G. Hyland Buchalter PC

STE 1900

Atlanta, GA 30339

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

VOLITION

Scientific and technological services, namely, custom design of chemical reagents and biological assays and research, all in the field of epigenetics and nucleosomes; Industrial research and scientific analysis in the field of epigenetics and nucleosomes; research and development services in the field of biotechnology, medical technology, assays, medical diagnostics, diagnostic reagents, substance Read More

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Medical services and veterinary services; diagnostic medical testing and treatment of disorders, namely, cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, and disorders associated with neutrophil extracellular traps (NETs); medical analysis services relating to the treatment of persons and animals; health care; hospital services; Veterinary services, namely, advisory of medical, diagnostic or surgical services for animals; human tissue bank services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical clinic services; medical screening; medical equipment rental; epigenetic testing for medical purposes, namely, for diagnosing disease, monitoring disease and treatment efficacy; medical analysis for the diagnosis and treatment of persons and animals; Medical and health care services in the field of DNA, genetics and genetic testing; genetic testing of animals for diagnostic or treatment purposes; genetic testing of animals for diagnostic or treatment purposes; DNA and RNA analysis services for medical purposes in the field of cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); Medical diagnosis and prognosis in the field of diseases related to epigenetic and nucleosomal changes, namely cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); genetic testing for medical purposes; Blood analysis services for diagnostic purposes provided by medical laboratories; Veterinary analysis services for diagnostic and treatment purposes provided by veterinary laboratories


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [042]
Computer & Software Services & Scientific Services


Scientific and technological services, namely, custom design of chemical reagents and biological assays and research, all in the field of epigenetics and nucleosomes; Industrial research and scientific analysis in the field of epigenetics and nucleosomes; research and development services in the field of biotechnology, medical technology, assays, medical diagnostics, diagnostic reagents, substances, preparations and materials, detection of cancer and other diseases; scientific consulting in the field of research and development of biotechnology, medical technology, assays, medical diagnostic reagents, and technology for detecting cancer and other diseases; Providing analytical reagent sample testing and diagnostics services for others for scientific research purposes in the field of epigenetics and nucleosomes; Product design and development in the field of medical diagnostic testing apparatus and reagents; Blood analysis services for scientific research purposes; Veterinary research laboratory services; DNA and RNA analysis services for scientific research purposes in the field of cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant health, thrombosis, vascular damage, inflammation, disorders associated with the immune system and disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS)


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [010]
Medical Instrument Products


Surgical apparatus and instruments for medical and veterinary use; medical and therapeutic apparatus and instruments for use in treatment of cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS) in humans and animals; Medical and veterinary devices for diagnosing cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, disorders associated with neutrophil extracellular traps (NETs) pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); Medical diagnostic apparatus for analyzing and measuring cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); medical apparatus, instruments and equipment for use in the diagnosis, monitoring and treatment of cancer; medical apparatus, instruments and equipment for use in the monitoring and diagnosis of sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage and inflammation, disorders associated with neutrophil extracellular traps (NETs) and pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); medical apparatus, instruments and equipment for use in monitoring the immune system, namely, for monitoring blood properties; Medical diagnostic apparatus for testing for cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); Medical diagnostic apparatus for use with chemical and biological reagents, for testing for cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); Medical apparatus for use in carrying out diagnostic assays; Medical apparatus, equipment and instruments for monitoring diseases namely, cancer sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); apparatus for DNA and RNA testing for medical purposes; Medical apparatus for use in regeneration of transplant tissues and organs; blood testing apparatus; dialyzers; apheresis devices for medical use; structural parts for all the aforesaid goods


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Pharmaceutical, chemical, biological, medical preparations for treating diseases caused by epigenetic and nucleosomal changes, namely, cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); biological tissue cultures for medical, therapeutic and veterinary purposes for use in the fields of epigenetics and nucleosomes; chemical and biological reagents for medical, therapeutic and veterinary purposes for use in the fields of epigenetics and nucleosomes; Diagnostic reagents, preparations and substances for medical use in the field of epigenetics and nucleosomes; diagnostic reagents for medical and veterinary use; Diagnostic reagents for medical use for in vitro diagnosis; Diagnostic preparations for medical purposes for detection, monitoring and diagnosis of cancer, sepsis, Covid-19, infection, dementia, Alzheimer's disease, thrombosis, vascular damage and inflammation, autoimmune diseases, and disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); Pharmaceutical preparations for the treatment of conditions related to in vivo and ex vivo organ and tissue transplant; Medical diagnostic assays for stem cell differentiation status; blood for medical and veterinary purposes; blood plasma; cultures of microorganisms for medical and veterinary use; diagnostic biomarker reagents for medical and veterinary purposes; Transplants, namely, living human allograft tissue


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [001]
Chemical Products


Chemicals and biological preparations used in industry and science; chemical and biological reagents for use in industry and science; diagnostic reagents for scientific and research purposes; chemical and biological preparations and reagents for use in diagnostic and analytical tests, including in vitro diagnostic laboratory tests, for scientific purposes and not for medical or veterinary purposes; Reagents for scientific use in the field of life sciences; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating cancer, sepsis, COVID-19, infection, dementia, Alzheimer's disease, transplant-related conditions, thrombosis, vascular damage, inflammation, disorders associated with the immune system, disorders associated with neutrophil extracellular traps (NETs), pneumonia, influenza, acute respiratory distress syndrome (ARDS), septic shock, trauma, organ failure, and multiple organ dysfunction syndrome (MODS); assays for testing stem cell differentiation status, other than for medical or veterinary use


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98208918

Mark Type

No Service Mark

Attorney Docket Number

No D6747-3440

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
18th Nov 2024WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST
17th Oct 2024APPROVED FOR PUB - PRINCIPAL REGISTER
11th Sep 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
11th Sep 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
11th Sep 2024TEAS/EMAIL CORRESPONDENCE ENTERED
25th Jun 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
25th Jun 2024NON-FINAL ACTION WRITTEN
25th Jun 2024NON-FINAL ACTION E-MAILED
23rd May 2024ASSIGNED TO EXAMINER
13th Oct 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED